279 related articles for article (PubMed ID: 28559215)
1. Physicochemical characterization of pH-responsive and fusogenic self-assembled non-phospholipid vesicles for a potential multiple targeting therapy.
Di Francesco M; Celia C; Primavera R; D'Avanzo N; Locatelli M; Fresta M; Cilurzo F; Ventura CA; Paolino D; Di Marzio L
Int J Pharm; 2017 Aug; 528(1-2):18-32. PubMed ID: 28559215
[TBL] [Abstract][Full Text] [Related]
2. Niosomes as Drug Nanovectors: Multiscale pH-Dependent Structural Response.
Marianecci C; Di Marzio L; Del Favero E; Cantù L; Brocca P; Rondelli V; Rinaldi F; Dini L; Serra A; Decuzzi P; Celia C; Paolino D; Fresta M; Carafa M
Langmuir; 2016 Feb; 32(5):1241-9. PubMed ID: 26740247
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
[TBL] [Abstract][Full Text] [Related]
4. Amphiphilic polymer-mediated formation of laponite-based nanohybrids with robust stability and pH sensitivity for anticancer drug delivery.
Wang G; Maciel D; Wu Y; Rodrigues J; Shi X; Yuan Y; Liu C; Tomás H; Li Y
ACS Appl Mater Interfaces; 2014 Oct; 6(19):16687-95. PubMed ID: 25167168
[TBL] [Abstract][Full Text] [Related]
5. Chitosan-tripolyphosphate nanoparticles functionalized with a pH-responsive amphiphile improved the in vitro antineoplastic effects of doxorubicin.
Nogueira-Librelotto DR; Scheeren LE; Vinardell MP; Mitjans M; Rolim CMB
Colloids Surf B Biointerfaces; 2016 Nov; 147():326-335. PubMed ID: 27543694
[TBL] [Abstract][Full Text] [Related]
6. Engineering extracellular vesicles mimetics for targeted chemotherapy of drug-resistant ovary cancer.
Liu X; Liu G; Mao Y; Luo J; Cao Y; Tan W; Li W; Yu H; Jia X; Li H
Nanomedicine (Lond); 2024 Jan; 19(1):25-41. PubMed ID: 38059464
[TBL] [Abstract][Full Text] [Related]
7. Imaging-Guided Drug Release from Glutathione-Responsive Supramolecular Porphysome Nanovesicles.
Xu XD; Zhao L; Qu Q; Wang JG; Shi H; Zhao Y
ACS Appl Mater Interfaces; 2015 Aug; 7(31):17371-80. PubMed ID: 26186168
[TBL] [Abstract][Full Text] [Related]
8. Tumor Targeting Synergistic Drug Delivery by Self-Assembled Hybrid Nanovesicles to Overcome Drug Resistance.
Gong MQ; Wu C; He XY; Zong JY; Wu JL; Zhuo RX; Cheng SX
Pharm Res; 2017 Jan; 34(1):148-160. PubMed ID: 27738951
[TBL] [Abstract][Full Text] [Related]
9. Dual stimuli polysaccharide nanovesicles for conjugated and physically loaded doxorubicin delivery in breast cancer cells.
Pramod PS; Shah R; Jayakannan M
Nanoscale; 2015 Apr; 7(15):6636-52. PubMed ID: 25797322
[TBL] [Abstract][Full Text] [Related]
10. pH sensitive surfactant-stabilized Fe
Dutta B; Shetake NG; Barick BK; Barick KC; Pandey BN; Priyadarsini KI; Hassan PA
Colloids Surf B Biointerfaces; 2018 Feb; 162():163-171. PubMed ID: 29190467
[TBL] [Abstract][Full Text] [Related]
11. pH-responsive cationic liposome for endosomal escape mediated drug delivery.
Rayamajhi S; Marchitto J; Nguyen TDT; Marasini R; Celia C; Aryal S
Colloids Surf B Biointerfaces; 2020 Apr; 188():110804. PubMed ID: 31972443
[TBL] [Abstract][Full Text] [Related]
12. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.
Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M
Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219
[TBL] [Abstract][Full Text] [Related]
13. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy.
Wu XL; Kim JH; Koo H; Bae SM; Shin H; Kim MS; Lee BH; Park RW; Kim IS; Choi K; Kwon IC; Kim K; Lee DS
Bioconjug Chem; 2010 Feb; 21(2):208-13. PubMed ID: 20073455
[TBL] [Abstract][Full Text] [Related]
14. mPEGylated solanesol micelles as redox-responsive nanocarriers with synergistic anticancer effect.
Qin B; Liu L; Wu X; Liang F; Hou T; Pan Y; Song S
Acta Biomater; 2017 Dec; 64():211-222. PubMed ID: 28963017
[TBL] [Abstract][Full Text] [Related]
15. pH-Triggered Surface Charge Reversed Nanoparticle with Active Targeting To Enhance the Antitumor Activity of Doxorubicin.
Du JB; Cheng Y; Teng ZH; Huan ML; Liu M; Cui H; Zhang BL; Zhou SY
Mol Pharm; 2016 May; 13(5):1711-22. PubMed ID: 26998644
[TBL] [Abstract][Full Text] [Related]
16. Self-Assembled Cationic Biodegradable Nanoparticles from pH-Responsive Amino-Acid-Based Poly(Ester Urea Urethane)s and Their Application As a Drug Delivery Vehicle.
He M; Potuck A; Kohn JC; Fung K; Reinhart-King CA; Chu CC
Biomacromolecules; 2016 Feb; 17(2):523-37. PubMed ID: 26650653
[TBL] [Abstract][Full Text] [Related]
17. Self-assembled polymer/inorganic hybrid nanovesicles for multiple drug delivery to overcome drug resistance in cancer chemotherapy.
Gong MQ; Wu JL; Chen B; Zhuo RX; Cheng SX
Langmuir; 2015 May; 31(18):5115-22. PubMed ID: 25927163
[TBL] [Abstract][Full Text] [Related]
18. Robust, active tumor-targeting and fast bioresponsive anticancer nanotherapeutics based on natural endogenous materials.
Sun B; Deng C; Meng F; Zhang J; Zhong Z
Acta Biomater; 2016 Nov; 45():223-233. PubMed ID: 27576338
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional stable and pH-responsive polymer vesicles formed by heterofunctional triblock copolymer for targeted anticancer drug delivery and ultrasensitive MR imaging.
Yang X; Grailer JJ; Rowland IJ; Javadi A; Hurley SA; Matson VZ; Steeber DA; Gong S
ACS Nano; 2010 Nov; 4(11):6805-17. PubMed ID: 20958084
[TBL] [Abstract][Full Text] [Related]
20. Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors.
Jang SC; Kim OY; Yoon CM; Choi DS; Roh TY; Park J; Nilsson J; Lötvall J; Kim YK; Gho YS
ACS Nano; 2013 Sep; 7(9):7698-710. PubMed ID: 24004438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
